Difenoximide or difenoximide hydrochloride
- Level
- Commodity
- Parent
- 51172100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51172124This classification denotes an antispasmotic agent with the molecular formulas C32H31N3O4 and C32H31N3O4.ClH, preparations that US FDA regulates as active ingredients or moieties under Unique Ingredient Identifiers 8UG1323C03 and 6GEY4W769K, the base compound being chemically known as 4-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)-alpha,alpha,4-triphenyl-1-piperidinebutanenitrile but generally known as difenoximide, which bears US NIH Compound Identifier 39481. European Medicines Agency schedules Difenoximide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07122MIG. The term DIFENOXIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). DIFENOXIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule difenoximide and its salts under HS 29333999 and SITC 51574. As of Q4 2014, DIFENOXIMIDE remains the US FDA Preferred Term for this commodity. Difenoximide bears US NLM NCI C73162 and C77288. SMILES: O(N1C(=O)CCC1=O)C(=O)C1(CCN(CC1)CCC(C1CCCCC1)(C1CCCCC1)C#N)C1CCCCC1 (base) or C1CCC(CC1)C2(CCN(CC2)CCC(C#N)(C3CCCCC3)C4CCCCC4)C(=O)ON5C(=O)CCC5=O.CL.
Same parent
Under 51172100 · 78Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.